Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis

NCT02053909 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Saphenous Vein Graft Disease

Interventions

DRUG: Aspirin
DRUG: Ticagrelor

Sponsor

Boca Raton Regional Hospital

Collaborators

[object Object]
[object Object]